SCIENTURE Announces Third Patent Grant for ARBLI™ (losartan potassium) Oral Suspension, Strengthening Long-Term Market Exclusivity Through 2041
Corroborated by 2 sources from 2 publishers
globalgeneral4h ago
TL;DR
Sources
1
Business Insider Markets News
https://markets.businessinsider.com/news/stocks/scienture-announces-third-patent-grant-for-arbli-losartan-potassium-oral-suspension-strengthening-long-term-market-exclusivity-through-2041-1036113058
5h ago
2
Yahoo Finance News
https://finance.yahoo.com/markets/stocks/articles/abivax-abvx-announces-90m-agreement-131619226.html
4h ago